Outstanding Talent, Outstanding Management
Metabolon has assembled a group of talented, experienced managers to develop and execute its business plan. We also have an impressive staff that includes specialists in biochemistry, mass spectrometry, informatics and software development.
Rohan F. Hastie, PhD
President & Chief Executive Officer
Dr. Hastie has served as president and CEO at Metabolon since May 2018. He joined the company in 2017 as chief business officer to oversee critical strategic initiatives within the Company's precision medicine, population health, and pharmaceutical and life sciences services business units and guide global commercial development. Prior to joining Metabolon, he was president of Arrow Life Sciences & Healthcare, a consulting firm specializing in commercialization and operational excellence for life sciences companies. Prior to that, he held various senior leadership positions in diagnostics and corporate development at Hologic, Inc., including president of Hologic Diagnostics. Before Hologic, Dr. Hastie worked at the strategy consulting company PA Consulting Group in their Life Sciences and Technology group, where he consulted for a wide range of companies in the pharmaceutical, biotechnology and diagnostics industries. He has a PhD in molecular genetics from Queen Elizabeth Medical School in Birmingham UK and a degree in biological sciences from the University of Birmingham.
Stephen J. Furlong, M.S.
Senior Vice President, Finance & Corporate Secretary
Mr. Furlong is a commercially focused finance executive with over 32 years of experience spanning four different industries. Prior to joining Metabolon, he was CFO at Rapid Micro Biosystems, a creator of innovative products for fast, accurate detection of microbial contamination. Prior to that, Mr. Furlong served as Senior Vice President, Finance and Sales Administration, at Hologic, Inc., a global leader in women's health solutions. Prior to his 14 years at Hologic, he served in various finance roles at Safety 1st, Stratus Computer, Inc. and Raytheon Company. He has a Master of Science in Finance degree from Bentley University and a BA in political science from The Pennsylvania State University.
Amanda S. Mancuso, MBA, PHR
Vice President, Human Resources
Ms. Mancuso serves as Metabolon’s Vice President of Human Resources where she translates the company’s vision into actionable strategies that engage employees and accelerate achievement. Ms. Mancuso was the Chief of Staff at SCYNEXIS, Inc for 14 years where she was responsible for human resources, public relations and communications. She has also held leadership positions at Italian pharmaceutical company Chiesi USA, Inc. and Aventis. Ms. Mancuso, having a degree in public relations, guides her unique leadership style in which she approaches every issue as a communications challenge rather than one labeled “HR.” Ms. Mancuso received her MBA from Duke University’s Fuqua School of Business and her BS from Appalachian State University.
Vice President, Global Marketing
Mrs. Johnson is Metabolon’s Vice President of Global Marketing, leading global portfolio strategy, brand and reputation management, demand generation and marketing communications. Before joining Metabolon, Ms. Johnson was Vice President of Marketing for Patheon, by Thermo Fisher Scientific. She also held senior leadership roles with Covance Laboratories and Baxter Healthcare Corporation. Ms. Johnson earned her MBA from Northwestern University’s Kellogg School of Management and her BA from Marquette University.
President, International Business
Michael Rasche is President and General Manager of Metabolon’s International Business. His track record in international business expansion in Pharma, Diagnostics, and Biotech contributes to advancing Metabolon's position as the world leader in metabolomics. Mr. Rasche brings 28 years of experience in the healthcare and life science arena, with a focus on the interface between Pharma and Diagnostics. Prior to joining Metabolon, Mr. Rasche served as the Chief Commercial Officer at Definiens. Prior to Definiens, Mr. Rasche was Corporate Vice President of Global Commercial Operations at Ayoxxa and held leadership positions with Dako (today Agilent), Roche and Bayer Diagnostics, across multiple countries in Europe and the Americas.
Vice President, Sales
Charles (Chuck) Wayland is an experienced sales executive with a demonstrated history of success working in the biotechnology industry. His expertise spans multiple life sciences disciplines, including metabolomics, genomics, diagnostics, proteomics, and personalized medicine. Before joining Metabolon, Mr. Wayland was Vice President of Sales at Progentity, managing the company’s genetic testing portfolio. Before that, he held the position as Vice President of North American Sales for Qiagen. Mr. Wayland has also held senior roles at Digene and Applied Imaging. He earned his BS in Management from Texas Tech University.